BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing

Go back to BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
(AMEX: BNXTF) Delayed: 0.23 --0 (-0%)
Previous Close $0.23    52 Week High
Open $0.23    52 Week Low
Day High $0.23    P/E N/A 
Day Low $0.22    EPS
Volume 2,907